Use of Adalimumab in young patients with chronic uveitis in whom infliximab loses its efficacy

相似書籍

• Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
  由: Simonini, G, et al.
  出版: (2011)
• Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
  由: Simonini, Gabriele, et al.
  出版: (2013)
• PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
  由: Moretti, D, et al.
  出版: (2013)
• Clinical and Transcriptional Response to the Long-Acting Interleukin-1 Blocker Canakinumab in Blau Syndrome-Related Uveitis
  由: Simonini, Gabriele, et al.
  出版: (2013)
• PReS-FINAL-2211: NOD2/CARD15 polymorphisms and clinical features in patients with non-infectious uveitis
  由: Marrani, E, et al.
  出版: (2013)